Editorial Series
Search for
Sort by 
Page
Showing 1 - 19 of 19 documents.
Editorial series
Nov 6, 2009 09:50 EST
Raised in a blue-collar neighborhood of Somerville, MA, Dr Bob Harrington was blessed to have a strong family and the Jesuits on his side as he traveled from "Yankee" Boston to Duke University. Join him as he tells his story to Dr Rob Califf.
Editorial series
Oct 30, 2009 12:35 EDT
How do regulatory pathways differ in the US and UK? Drs Harrington, Bhatt, and Cleland share their experiences and offer insight on how to support innovative research.
Editorial series
Oct 23, 2009 10:40 EDT
Dr Melissa Walton-Shirley talks to Dr Nassir Marrouche about the results of RE-LY, the impact of dronedarone on the treatment of atrial fibrillation, and his hopes for the future of MRI-guided ablation.
Editorial series
Oct 16, 2009 10:00 EDT
Join heartwire's Lisa Nainggolan as she talks to Drs Franz Messerli and Melissa Walton-Shirley about the results of the KYOTO HEART Study, what they mean for North American and European populations, and the future role of angiotensin-receptor blockers (ARBs).
Editorial series
Sep 22, 2009 11:50 EDT
Exactly three years after the DES firestorm ignited the World Congress of Cardiology in Barcelona, heartwire's Shelley Wood sifts through the ashes with Drs Tony Gershlick, Christian Spaulding, and Renu Virmani in a discussion on DES safety and what we've learned since September 2006.
Editorial series
Sep 15, 2009 14:10 EDT
Dr Robert Califf sits down with Drs Alfred Bove, Jack Lewin, and Clyde Yancy and AHA CEO Nancy Brown to talk about the ACC and the AHA and their role in the debate on healthcare reform.
The Cardiology Show
Sep 2, 2009 11:15 EDT
Dr Valentin Fuster returns to the city where he was born for a scintillating discussion with Drs Fox, Gershlick, Marrouche, Messerli, Spaulding, Vergheugt, Virmani, and Yancy about the miracle of RE-LY and the striking success of ticagrelor in the PLATO study.
Editorial series
Jun 29, 2009 11:00 EDT
Dr Robert Harrington talks to Drs Sanjay Kaul and Harlan Kurmholz about the SYNTAX trial in light of the recent quality-of-life and cost analysis.
Editorial series
1 COMMENT - Jun 1, 2009 10:20 EDT
Join Dr Robert Califf for a probing and personal interview with Dr Steve Nissen, about his activist days at the University of Michigan and the development of IVUS, to how he ended up at the Cleveland Clinic and what he thinks about the future of medicine in America.
Editorial series
May 22, 2009 09:20 EDT
Dr Harlan Krumholz talks to Drs Sanjay Kaul and Robert Harrington about EARLY ACS and the issues around upstream use of GP IIb/IIIa inhibitors.
Editorial series
1 COMMENT - Apr 29, 2009 00:00 EDT
With the global trend leaning toward increased use of transradial access, our international panel reports on standard practice at their respective institutions and the key issues that influence it such as bleeding, access-site complications, stroke risk, patient mobility, and operator experience. Join Drs Kandzari (US), Feres (Brazil), Le May (Canada), and Steg (France) for this thoughtful and practical discussion.
The Cardiology Show
Apr 2, 2009 15:35 EDT
Join Drs Valentin Fuster, Anne Curtis, Timothy Gardner, Barry Greenberg, Cindy Grines, Bob Harrington, Sanjay Kaul, Harlan Krumholz, and Salim Yusuf as they unravel the STICH trial and debate the lessons learned from PROTECT-AF in Part 1 of the Cardiology Show. In Part 2 of the program, the JUPITER trial is back on the table and our experts give their opinion on the polypill following the results of the TIPS study.
Ten years in review
1 COMMENT - Dec 3, 2008 14:30 EST
As theheart.org enters its 10th year join editor-in-chief, Dr Eric Topol, and his guests for a second look at the top news from the past decade. Throughout the coming months, we'll revisit the most important story from each of the last 10 years and ask: How has practice been affected? With time and perspective, what has changed and what have we learned?
Cardiology panels
Oct 28, 2008 12:00 EDT
Join Drs Raymond Gibbons, Antonio Colombo, William Boden, Ph Gabriel Steg, and Valentin Fuster for another look at the COURAGE trial, as they discuss the latest data and talk about where things stand now on the larger controversy.
Cardiology panels
Oct 22, 2008 09:20 EDT
Dr Melissa Walton-Shirley talks to Drs Ph Gabriel Steg and Raymond Gibbons about the differences in STEMI care on both sides of the Atlantic and what US cardiologists can learn from their colleagues in Europe.
Cardiology panels
Oct 3, 2008 13:40 EDT
Drs Antonio Colombo and Renu Virmani talk about the one-year results of the SYNTAX trial, the importance of understanding registries, and the complex issue of clopidogrel duration with drug-eluting stents in a discussion moderated by heartwire journalist Shelley Wood.
Cardiology panels
May 22, 2008 09:00 EDT
Dr Gregg Stone talks to Drs Keith Fox and Gilles Montalescot about the implications of the DES meta-analysis and the interventional cardiology late-breaking trials presented at the joint SCAI-ACC i2 2008 Scientific Sessions.
Cardiology panels
Jan 15, 2008 15:49 EST
Getting the lowdown on HORIZONS

Drs Keith Fox and Gregg Stone go into the details of this practice-changing trial as they address concerns about acute stent thrombosis and talk about ways to improve outcomes, in a discussion moderated by Dr James Ferguson.
Cardiology panels
Jan 10, 2008 09:46 EST
Debate continues over drug-eluting stents Drs Gregg Stone and Renu Virmani share their hopes and concerns for PCI and drug-eluting stents as they weigh in on the COURAGE nuclear substudy and the latest registry data on DES vs BMS in a discussion moderated by heartwire journalist Shelley Wood.

Search for
Sort by 
Page
Showing 1 - 19 of 19 documents.
button
Previews
Featured programs
Poll
Would you recommend daily aspirin for primary prevention in the average 82-year-old man or women with no obvious bleeding diathesis?
See: Aspirin: More evidence that low dose is all that is needed
Yes, at greater than or equal to 100 mg/day
Yes, at less than 100 mg/day
No

Inside: Acute Coronary Syndromes
Acute Coronary Syndromes
Oct 26, 2009 08:59 EDT
PLATO, CURRENT-OASIS 7, COGENT, recent meetings have seen some blockbuster presentations in the area of antiplatelet/antithrombotic therapy. What is your response to these data? Answer our 4 short polling questions and learn your peers' responses.